Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18440894 | N-(PYRIMIDIN-2-YLCARBAMOTHIOYL) BENZAMIDE AS AN ECO-FRIENDLY INSECTICIDAL AGENT AGAINST SPODOPTERA LITTORALIS (BOISD.) | February 2024 | June 2024 | Allow | 4 | 0 | 0 | No | No |
| 18506961 | TADALAFIL ORAL TRANSMUCOSAL FILM | November 2023 | March 2024 | Allow | 4 | 1 | 0 | Yes | No |
| 18383326 | N-(PYRIMIDIN-2-YLCARBAMOTHIOYL) BENZAMIDE AS AN ECO-FRIENDLY INSECTICIDAL AGENT AGAINST SPODOPTERA LITTORALIS (BOISD.) | October 2023 | November 2024 | Abandon | 13 | 2 | 1 | No | No |
| 18374342 | Broad-Spectrum Antimicrobial, Biocompatible and Preservative-Free Functionalized Fullerenes Ophthalmic Solution with Reactive Oxygen Species Scavenging and Advanced Targeting, Penetration, and Hydration. | September 2023 | April 2024 | Allow | 7 | 1 | 0 | Yes | No |
| 18477161 | EPINEPHRINE FORMULATIONS | September 2023 | December 2024 | Allow | 15 | 3 | 0 | No | No |
| 18470256 | EPINEPHRINE FORMULATIONS | September 2023 | April 2025 | Abandon | 18 | 2 | 0 | No | No |
| 18070570 | Method of Improving the Appearance of Skin | November 2022 | September 2024 | Allow | 22 | 2 | 0 | No | No |
| 17988031 | ARCTIGENIN LIQUID NANO-PREPARATION AND PREPARATION METHOD THEREOF | November 2022 | June 2024 | Allow | 19 | 2 | 0 | No | No |
| 17985933 | OIL-IN-WATER TYPE COSMETIC COMPOSITION WITH VISIBLE OIL PARTICLES | November 2022 | May 2024 | Abandon | 18 | 2 | 0 | No | No |
| 17969309 | Fiber-Reinforced Bio-Material Composition and Methods of Use | October 2022 | March 2025 | Allow | 29 | 2 | 0 | No | No |
| 18046553 | ORODISPERSIBLE FORMULATIONS | October 2022 | November 2024 | Allow | 25 | 5 | 0 | Yes | No |
| 17936440 | LEAVE-ON HAIR TREATMENT COMPOSITIONS | September 2022 | March 2024 | Allow | 18 | 2 | 0 | Yes | No |
| 17935651 | CLEANSING COMPOSITIONS COMPLETELY BASED ON BIO-RENEWABLE SOURCES | September 2022 | August 2023 | Allow | 10 | 1 | 0 | No | No |
| 17949576 | ORAL SUPPLEMENT FOR PREVENTING COLIC IN HORSES | September 2022 | March 2024 | Allow | 17 | 2 | 0 | No | No |
| 17900091 | NOVEL ENVIRONMENT-FRIENDLY HERBICIDE | August 2022 | November 2024 | Abandon | 26 | 1 | 1 | No | No |
| 17898685 | DISSOLVABLE SOLID STRUCTURE COMPRISING FIRST AND SECOND POLYMERIC STRUCTURANTS | August 2022 | May 2025 | Allow | 33 | 5 | 0 | Yes | No |
| 17815268 | HAIR COLORING WITH COCONUT OIL | July 2022 | May 2025 | Allow | 33 | 3 | 0 | Yes | No |
| 17852555 | Original Healing Gel | June 2022 | March 2024 | Abandon | 21 | 2 | 0 | No | No |
| 17826035 | CLAY MASK FOR TREATING SKIN | May 2022 | December 2023 | Abandon | 19 | 1 | 0 | No | No |
| 17744257 | COSMETIC COMPOSITION AND METHOD | May 2022 | April 2025 | Abandon | 35 | 3 | 1 | Yes | No |
| 17738697 | Shampoo Compositions Containing a Sulfate-Free Surfactant System and Sclerotium Gum Thickener | May 2022 | August 2024 | Allow | 27 | 2 | 0 | Yes | Yes |
| 17730382 | HAIR COMPOSITIONS | April 2022 | December 2023 | Allow | 20 | 1 | 0 | No | No |
| 17686880 | PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF | March 2022 | June 2025 | Allow | 39 | 1 | 1 | No | No |
| 17685487 | MOLDABLE COMPOSITION FOR SOLID WASHING AGENT AND METHOD FOR MOLDING THE SAME | March 2022 | August 2024 | Allow | 30 | 2 | 0 | Yes | No |
| 17685574 | TREATMENT COMPOSITION FOR NASAL AND ORAL DRYNESS, NOSEBLEEDS, AND ALLERGY SYMPTOMS | March 2022 | March 2024 | Allow | 25 | 2 | 0 | Yes | No |
| 17685090 | EPINEPHRINE FORMULATIONS | March 2022 | June 2025 | Allow | 40 | 1 | 0 | No | No |
| 17652518 | BLEACHING COMPOSITION FOR KERATIN FIBERS | February 2022 | December 2024 | Allow | 34 | 3 | 0 | Yes | No |
| 17676628 | PETROLATUM ALTERNATIVE FROM RENEWABLE SOURCES | February 2022 | November 2023 | Abandon | 21 | 1 | 0 | No | No |
| 17561872 | Alcohol Soluble Biodegradable Compositions | December 2021 | May 2024 | Allow | 29 | 1 | 1 | No | No |
| 17560594 | PEGYLATED LIPOSOMES AND METHODS OF USE | December 2021 | January 2025 | Allow | 37 | 1 | 0 | No | No |
| 17553172 | PORTION UNIT WITH COSMETIC AGENT FOR LIGHTENING KERATINOUS FIBERS, ESPECIALLY HUMAN HAIR | December 2021 | December 2024 | Abandon | 36 | 1 | 0 | No | No |
| 17553146 | PORTION UNIT WITH COSMETIC PRODUCT FOR OXIDATIVE COLOR CHANGE OF KERATINOUS FIBERS | December 2021 | September 2024 | Abandon | 33 | 2 | 0 | No | No |
| 17537856 | AQUEOUS COMPOSITION OF EPYRIFENACIL, FLUMIOXAZIN AND PYROXASULFONE | November 2021 | March 2025 | Allow | 40 | 4 | 0 | No | No |
| 17523105 | SYSTEM AND METHOD OF TREATING INFLAMMATORY LUNG DISEASES | November 2021 | December 2023 | Abandon | 25 | 1 | 1 | No | No |
| 17517763 | FAST-DISINTEGRATING SOLID HERBICIDE COMPOSITION AND THE USE THEREOF | November 2021 | February 2024 | Abandon | 27 | 1 | 1 | No | No |
| 17495104 | STABLE FORMULATIONS OF LIPIDS AND LIPOSOMES | October 2021 | September 2024 | Allow | 36 | 1 | 0 | No | No |
| 17445089 | LIPOSOMAL FORMULATION FOR JOINT LUBRICATION | August 2021 | September 2024 | Allow | 37 | 1 | 0 | No | No |
| 17372952 | SMALL MOLECULE PATHOGEN DISPERSAL AGENT | July 2021 | December 2024 | Abandon | 42 | 4 | 0 | No | No |
| 17312927 | SOLID FORMULATION OF HERBICIDAL COMPOSITION AND PREPARING METHOD THEREOF | June 2021 | October 2024 | Abandon | 40 | 1 | 0 | No | No |
| 17299636 | NANOEMULSION HYDROPHOBIC SUBSTANCES | June 2021 | July 2024 | Abandon | 37 | 1 | 1 | No | No |
| 17306244 | MICRONIZED LIPIDS | May 2021 | September 2024 | Allow | 41 | 3 | 1 | Yes | No |
| 17306261 | MICRONIZED LIPIDS | May 2021 | September 2024 | Allow | 41 | 3 | 1 | Yes | No |
| 17284984 | A CHEWABLE TABLET AND METHOD OF PREPARING THE SAME | April 2021 | September 2024 | Allow | 42 | 3 | 0 | No | No |
| 17283375 | LIP COSMETIC COMPOSITION AND USE THEREOF | April 2021 | September 2023 | Abandon | 29 | 1 | 0 | No | No |
| 17283216 | SILICON FREE HAIR CONDITIONING COMPOSITION | April 2021 | June 2025 | Allow | 50 | 7 | 0 | No | No |
| 17282085 | IMPROVED-STRENGTH HARD CAPSULE AND PRODUCTION METHOD FOR SAME | April 2021 | March 2025 | Abandon | 47 | 3 | 1 | No | No |
| 17281621 | ASENAPINE-CONTAINING ADHESIVE PATCH | March 2021 | September 2023 | Allow | 30 | 2 | 0 | No | No |
| 17218438 | HAIR CARE COMPOSITIONS | March 2021 | March 2023 | Allow | 24 | 1 | 0 | No | No |
| 17281312 | CORE-SHELL COMPOSITE AND A PROCESS OF PREPARING THE SAME | March 2021 | July 2024 | Abandon | 39 | 0 | 1 | No | No |
| 17281442 | SPHERICAL BEADS FOR USE IN PRODUCING PHARMACEUTICALLY ACTIVE PELLETS | March 2021 | July 2024 | Allow | 40 | 3 | 1 | No | No |
| 17213350 | SHEET TYPE MASK GEL COMPOSITION, MASK SHEET COMPRISING THE SAME, AND MANUFACTURING METHOD OF MASK SHEET | March 2021 | February 2024 | Allow | 35 | 1 | 1 | Yes | No |
| 17279768 | COSMETIC GEL COMPRISING A TRIGLYCERIDE OIL | March 2021 | May 2024 | Allow | 38 | 2 | 1 | Yes | No |
| 17279151 | COMPOSITION AND METHOD FOR SHAPING OR ALTERING THE SHAPE OF HAIR, METHOD FOR MANUFACTURING A COMPOSITION, KIT AND USES OF A COMPOSITION | March 2021 | December 2023 | Allow | 33 | 1 | 1 | No | No |
| 17208025 | COMPOSITION FOR CONTROLLING AND PREVENTING BACTERIAL WILT | March 2021 | May 2024 | Abandon | 38 | 2 | 0 | No | Yes |
| 17277825 | LIPOPHILIC TRANSPORT PARTICLES FOR COSMETIC OR PHARMACEUTICAL ACTIVE INGREDIENTS | March 2021 | June 2024 | Allow | 39 | 3 | 1 | Yes | Yes |
| 17277213 | HAIR TREATMENT COMPOSITION | March 2021 | August 2023 | Allow | 29 | 2 | 0 | Yes | No |
| 17275973 | STABILIZED CYCLOHEXANEDIONE OXIME COMPOSITION | March 2021 | May 2024 | Allow | 38 | 2 | 1 | Yes | No |
| 17275225 | METHOD OF CONTROLLING PESTS BY SEED TREATMENT APPLICATION OF A MESOIONIC COMPOUND OR MIXTURE THEREOF | March 2021 | November 2024 | Abandon | 45 | 3 | 1 | No | No |
| 17265692 | IMMUNOREACTANT CARRIER | February 2021 | March 2025 | Allow | 50 | 3 | 1 | No | No |
| 17140502 | LIPOSOME COMPOSITION AND METHOD FOR PRODUCING THE SAME | January 2021 | October 2024 | Allow | 45 | 4 | 0 | No | No |
| 16651062 | COMPOSITIONS AND METHODS FOR IMPROVING NITROGEN UTILIZATION IN A RUMINANT | March 2020 | November 2024 | Allow | 55 | 5 | 0 | Yes | No |
| 16235950 | SCALE UP SYNTHESIS OF SILICASOME NANOCARRIERS | December 2018 | March 2025 | Allow | 60 | 8 | 1 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner TIEN, LUCY MINYU.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 33.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner TIEN, LUCY MINYU works in Art Unit 1612 and has examined 61 patent applications in our dataset. With an allowance rate of 67.2%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 33 months.
Examiner TIEN, LUCY MINYU's allowance rate of 67.2% places them in the 21% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by TIEN, LUCY MINYU receive 2.23 office actions before reaching final disposition. This places the examiner in the 76% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by TIEN, LUCY MINYU is 33 months. This places the examiner in the 26% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +41.3% benefit to allowance rate for applications examined by TIEN, LUCY MINYU. This interview benefit is in the 90% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 30.8% of applications are subsequently allowed. This success rate is in the 53% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 28.6% of cases where such amendments are filed. This entry rate is in the 32% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 0% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 84% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 40.0% are granted (fully or in part). This grant rate is in the 38% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 0% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 0% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.